Saurabh Saha

Saurabh Saha, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Centessa Pharmaceuticals plc and Clarivate PLC. Over a trading history stretching from 16 November 2021 to 14 May 2026, the count stands at 61 filings.

Both buying and selling appear: 4 purchases worth €580k, against 27 sales worth €14.0M. Netting one side against the other leaves €13.4M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 21 share grants and 9 option exercises.

Half of the purchases are above €144k and half below. On 3 out of 4 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.

The record was last updated on 15 May 2026 with a share grant in Clarivate PLC. The clock since the last published purchase (5 March 2025) now reads 613 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.